GIST Support Wiki

 
CANADIAN'S - HEALTH CANADA'S SAP -SPECIAL ACCESS PROGRAMME TO MEDICATIONS

3/23/2013

There is a way to access REGORAFINIB (STIVARGA) OR OTHERS in Canada.

http://www.hc-sc.gc.ca/dhp-mps/acces/drugs-drogues/index-eng.php

Health Canada’s Special Access Programme (SAP) provides access to nonmarketed drugs for practitioners treating patients with serious or life-threatening conditions when conventional therapies have failed, are unsuitable, or unavailable. The SAP authorizes a manufacturer to sell a drug that cannot otherwise be sold or distributed in Canada. Drugs considered for release by the SAP include pharmaceutical, biologic, and radio-pharmaceutical products not approved for sale in Canada.

http://www.bccancer.bc.ca/NR/rdonlyres/D2AED198-E2C7-4DBB-9490-7B6A332610C4/61871/SAPchart_18Jan2014.pdf

Scroll down on the SAP chart to “regorafenib” OR THE MEDICATION YOU ARE LOOKING FOR and you will find the necessary contact information.